Smith Salley Wealth Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,570
Closed -$6.52M 266
2025
Q3
$6.52M Sell
14,570
-2,981
-17% -$1.35M 0.34% 60
2025
Q2
$8.55M Buy
17,551
+396
+2% +$226K 0.49% 50
2025
Q1
$10.6M Buy
17,155
+167
+1% +$94.9K 0.69% 45
2024
Q4
$9M Buy
16,988
+307
+2% +$173K 0.58% 46
2024
Q3
$10M Buy
16,681
+472
+3% +$268K 0.66% 47
2024
Q2
$8.79M Buy
16,209
+993
+7% +$569K 0.63% 46
2024
Q1
$9.77M Sell
15,216
-4,622
-23% -$2.81M 0.76% 42
2023
Q4
$11.6M Buy
19,838
+681
+4% +$381K 0.75% 42
2023
Q3
$9.96M Buy
19,157
+760
+4% +$395K 0.74% 43
2023
Q2
$9.96M Buy
18,397
+95
+0.5% +$51.9K 0.74% 45
2023
Q1
$9.84M Buy
18,302
+582
+3% +$297K 0.78% 41
2022
Q4
$9.04M Sell
17,720
-209
-1% -$102K 0.77% 45
2022
Q3
$7.83M Buy
17,929
+365
+2% +$176K 0.73% 43
2022
Q2
$8.24M Buy
17,564
+768
+5% +$375K 0.71% 47
2022
Q1
$8.51M Buy
16,796
+210
+1% +$101K 0.64% 45
2021
Q4
$8.78M Buy
16,586
+524
+3% +$252K 0.62% 47
2021
Q3
$7.47M Buy
16,062
+331
+2% +$156K 0.59% 47
2021
Q2
$7.46M Buy
+15,731
New +$7.55M 0.6% 45
2018
Q2
Sell
-943
Closed -$257K 181
2018
Q1
$257K Sell
943
-7
-0.7% -$1.85K 0.05% 155
2017
Q4
$231K Buy
+950
New +$216K 0.04% 168
2017
Q1
Sell
-1,615
Closed -$259K 176
2016
Q4
$259K Hold
1,615
0.05% 134
2016
Q3
$228K Sell
1,615
-200
-11% -$27.8K 0.05% 141
2016
Q2
$247K Buy
1,815
+60
+3% +$7.96K 0.06% 141
2016
Q1
$238K Hold
1,755
0.06% 139
2015
Q4
$263K Buy
1,755
+46
+3% +$6.8K 0.07% 132
2015
Q3
$228K Buy
1,709
+71
+4% +$9.94K 0.06% 138
2015
Q2
$215K Buy
+1,638
New +$203K 0.05% 148

Other funds holding CHE

Smith Salley Wealth Management's CHE Position: Q4 2025 in Review

Smith Salley Wealth Management sold out of Chemed (CHE) in Q4 2025, closing a stake of 14,570 shares — an estimated $6.52M sold.

Smith Salley Wealth Management first reported a position in CHE in Q2 2015 and held it in 27 quarters. The position peaked at $11.6M in Q4 2023. 516 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Smith Salley Wealth Management reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Smith Salley Wealth Management sold 14,570 Chemed shares in Q4 2025, an estimated $6.52M.
  • Smith Salley Wealth Management first reported a position in Chemed in Q2 2015 and held it in 27 quarters.
  • Smith Salley Wealth Management's Chemed position peaked at $11.6M in Q4 2023.
  • 516 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Smith Salley Wealth Management's 13F filing for Q4 2025, filed 27 Jan 2026.